Big Pharma Stocks: Who’s Leading The Race And Who’s Slipping?

Merck's wider drug moat and acquisition spree makes it a safer bet but VKTX can be the next LLY.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.